HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Fan Selected Research

Parkinson Disease (Parkinson's Disease)

1/2021R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.
1/2020Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation.
1/2020Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease.
1/2018Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils.
1/2018Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
8/2012The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
8/2009Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Fan Research Topics

Disease

70Breast Neoplasms (Breast Cancer)
01/2024 - 12/2008
49Neoplasms (Cancer)
01/2024 - 11/2005
30Triple Negative Breast Neoplasms
01/2024 - 06/2012
25Neoplasm Metastasis (Metastasis)
04/2024 - 01/2010
13Diabetic Nephropathies (Diabetic Nephropathy)
09/2023 - 11/2008
12Fibrosis (Cirrhosis)
01/2023 - 03/2012
12Gallstones (Gallstone)
05/2021 - 08/2006
10Inflammation (Inflammations)
10/2022 - 01/2010
9Infections
05/2022 - 07/2009
8Disease Progression
10/2021 - 01/2010
7Retinal Perforations
11/2023 - 03/2010
7Diabetic Retinopathy (Retinopathy, Diabetic)
09/2023 - 04/2009
7Hypertension (High Blood Pressure)
01/2023 - 05/2015
7Reperfusion Injury
01/2023 - 05/2008
7Type 2 Diabetes Mellitus (MODY)
12/2022 - 01/2010
7Parkinson Disease (Parkinson's Disease)
01/2021 - 08/2009
7Infarction (Infarctions)
01/2019 - 10/2007
6Retinal Detachment (Retinal Detachments)
01/2024 - 03/2012
6Macular Degeneration (Age-Related Maculopathy)
11/2023 - 08/2015
6Myopia
06/2023 - 06/2011
6Atrophy
06/2022 - 01/2016
5COVID-19
03/2022 - 10/2020
5Myocardial Infarction
02/2022 - 05/2008
5Body Weight (Weight, Body)
01/2022 - 04/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2023
4Hyperglycemia
10/2023 - 05/2008
4Chronic Renal Insufficiency
01/2023 - 04/2005
4Asthma (Bronchial Asthma)
10/2022 - 10/2013
4Adenocarcinoma of Lung
10/2022 - 08/2021
4Neutropenia
01/2022 - 10/2015
4Fever (Fevers)
06/2021 - 09/2012
4Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 04/2005
4Lymphatic Metastasis
12/2018 - 10/2010
3Epiretinal Membrane (Epiretinal Membranes)
03/2023 - 08/2015
3Acute Kidney Injury (Acute Renal Failure)
01/2023 - 03/2021
3Carcinogenesis
01/2022 - 01/2014
3Hemorrhage
01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2007
22Biomarkers (Surrogate Marker)IBA
02/2023 - 11/2008
18AnthracyclinesIBA
01/2022 - 01/2010
17ErbB Receptors (EGF Receptor)IBA
04/2024 - 05/2017
16Hormones (Hormone)IBA
01/2024 - 01/2011
13Capecitabine (Xeloda)FDA Link
12/2023 - 01/2010
12CholesterolIBA
01/2023 - 10/2007
11Retinaldehyde (Retinal)IBA
06/2023 - 03/2012
11human ERBB2 proteinIBA
02/2021 - 09/2012
11Taxoids (Taxanes)IBA
01/2021 - 01/2010
10Phosphotransferases (Kinase)IBA
01/2024 - 06/2015
9Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 12/2008
8Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 09/2012
8Epirubicin (Ellence)FDA LinkGeneric
01/2023 - 06/2012
8Indicators and Reagents (Reagents)IBA
01/2023 - 04/2009
8PlatinumIBA
01/2022 - 10/2014
8Trastuzumab (Herceptin)FDA Link
07/2021 - 07/2013
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 06/2012
7Glucose (Dextrose)FDA LinkGeneric
12/2022 - 03/2005
7Estrogen ReceptorsIBA
10/2021 - 06/2012
7taxaneIBA
01/2020 - 08/2010
6Tyrosine Kinase InhibitorsIBA
12/2023 - 09/2017
6CreatinineIBA
01/2023 - 04/2005
6LipidsIBA
01/2023 - 04/2014
6Carboplatin (JM8)FDA LinkGeneric
01/2022 - 06/2012
5pyrotinibIBA
12/2023 - 09/2017
5CalciumIBA
10/2023 - 02/2005
5RNA (Ribonucleic Acid)IBA
05/2023 - 01/2007
5Phenobarbital (Luminal)FDA Link
02/2022 - 12/2013
5Insulin (Novolin)FDA Link
01/2022 - 01/2010
5Vinorelbine (Navelbine)FDA LinkGeneric
07/2021 - 01/2010
5Aromatase InhibitorsIBA
01/2020 - 01/2011
4Peptides (Polypeptides)IBA
12/2023 - 01/2018
4Epidermal Growth Factor (EGF)IBA
11/2023 - 10/2019
4Sirolimus (Rapamycin)FDA Link
01/2023 - 10/2010
4EnzymesIBA
01/2023 - 01/2012
4AlbuminsIBA
01/2022 - 03/2016
4Therapeutic UsesIBA
11/2021 - 01/2007
4Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 04/2009
4Small Interfering RNA (siRNA)IBA
11/2021 - 02/2010
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2012
4CytokinesIBA
01/2021 - 11/2016
4Leucine (L-Leucine)FDA Link
01/2021 - 01/2018
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 04/2009
4DNA (Deoxyribonucleic Acid)IBA
09/2017 - 01/2007
4EndotoxinsIBA
08/2009 - 08/2006
3LipopolysaccharidesIBA
01/2024 - 03/2013
3Transcription Factors (Transcription Factor)IBA
10/2023 - 01/2018
3Messenger RNA (mRNA)IBA
01/2023 - 01/2014
3Triglycerides (Triacylglycerol)IBA
01/2023 - 02/2017
3AcidsIBA
05/2022 - 08/2009
3Blood Glucose (Blood Sugar)IBA
01/2022 - 09/2016
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 01/2015
3Docetaxel (Taxotere)FDA Link
01/2022 - 06/2012

Therapy/Procedure

40Therapeutics
12/2023 - 01/2010
30Drug Therapy (Chemotherapy)
02/2022 - 10/2010
13Adjuvant Chemotherapy
01/2023 - 06/2012
9Neoadjuvant Therapy
01/2022 - 09/2012
8Vitrectomy
01/2024 - 03/2010
6Traction
11/2023 - 08/2015
5Splenectomy
01/2019 - 03/2011
4Length of Stay
01/2022 - 10/2019
4Lasers (Laser)
01/2015 - 11/2005